Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, shared a post on X:
“40 years ago, a young physician submitted a paper reporting on the alteration of a gene called HER2/neu to Science.
He didn’t know that it was the beginning of one of the most remarkable scientific stories of the human kind, which would eventually impact the lives of Countless.”
Other articles featuring Paolo Tarantino on OncoDaily.
